Background: Stenotrophomonas maltophilia (S.maltophilia) is an intrinsically drug resistant opportunistic pathogen associated with serious infections in humans. Acquired resistance to trimethoprim-sulfamethoxazole (SXT,co-trimoxazole), the main stay of therapy against S. maltophilia ,has made its treatment more problematic. Objectives: This work aimed to determine the occurrence of SXT resistance among S. maltophilia isolated from Zagazig University Hospitals in Egypt and to assess the association of sul genes and integron1 with SXT-resistant isolates. Material and Methods: Thirty-two S.maltophilia isolates were identified in this study during the period from 2013 to 2015. Screening of SXT-resistant isolates was done by Kirby-Bauer method. Minimum inhibitory concentration(MIC) values for SXT were determined by agar dilution. S. maltophilia isolates were tested for the presence of sul1, sul2, sul3, and int 1 genes by multiplex polymerase chain reaction. Results: Amongst the 32 S. maltophilia isolates, 12(37.5%) were resistant to SXT. All SXT-resistant isolates were found to harbor sul1 gene and integron1. One of these isolates had sul2 gene (1/12,8.3% ). Meanwhile, sul3 gene was not detected in any of the SXT-resistant isolates. Only 2 of the 20 SXT-susceptible isolates was found to yield positive PCR results for sul1 gene, one of them gave positive result for class 1 Integron. The association of sul genes and Integrin1 with resistance to SXT had a statistically significant difference( P<0.0001). Conclusion: Our study indicated a high frequency of SXT resistance among clinical S.maltophilia isolates from Zagazig University Hospitals, in which sul genes and class 1 integron were found to have a major role.
INTRODUCTION
Stenotrophomonas maltophilia (S.maltophilia) is a glucose non fermentative, aerobic, motile Gram negative bacillus. It was first isolated in 1943 and named Bacterium booker. In 1961, it was re classified as a member of the genus Pseudomonas, then Xanthomonas in 1983 and later Stenotrophomonas in 1993 (1). It is commonly found in various environments such as water, soil, plants as well as in hospital settings (2).
These bacteria typically colonize areas of the body without causing infection. However, in severely ill, hospitalized patients, S. maltophilia can cause a wide range of serious infections, including nosocomial pneumonia, bacteremia, pulmonary infections, urinary tract infections, wound infections, skin and soft tissue infections, meningitis, and endocarditis, particularly with those having impaired immune system (1,2). This is facilitated by the organism's ability to survive on almost any humid surface, its tendency to form biofilm, and its employment of several mechanisms that confer resistance to a number of antimicrobial agents (3).
Factors that increase the risk for S. maltophilia infection include admission to an intensive care unit, prolonged hospitalization, HIV infection, cancer, cysticfibrosis, neutropenia, recent surgery, trauma, mechanical ventilation, and previous therapy with broad-spectrum antibiotics( 4). S. maltophilia has highlevel intrinsic resistance to many antibiotics owing to its multidrug-efflux pumps and low outer membrane permeability, which makes its infections difficult to manage (5). In addition to being intrinsically drugresistant pathogen, it can acquire antibiotic resistance by horizontal transfer of resistance genes located on plasmids, transposons and integrons (5). This has made the World Health Organization to classify S. maltophilia as one of the leading multidrug resistant organisms (MDROs) in hospital settings (6).
Trimethoprim/sulfamethoxazole (SXT, cotrimoxazole) is considered the first-line agent recommended for the treatment of S. maltophilia (7). However, SXT resistancein S. maltophilia has been widely increasing over recent years (8). This constitutes a great clinical problem, ast he range of effective antibiotic agents is even more limited in infections caused by co-trimoxazole-resistant S. maltophilia (9). Resistance to co-trimoxazole can result from mutations in the chromosomal dihydropteroate synthetase (DHPS) gene or more frequently from the acquisition of an alternative DHPS gene (sul), whose product has a lower affinity for sulfonamides (10).
The sul1 gene is mostly found linked to other resistance genes in class 1 integrons, while sul2 is usually located on small plasmids. Sul3, shares an amino acid identity of ∼40% with previously known resistant enzymes and it is a plasmid borne resistance gene. The genetic localization of sul genes on efficient mobile genetic structures probably contributes to the widespread of sulfonamides resistance (11). As no much information is currently available regarding the frequency of SXT resistance among S. maltophilia isolates in our hospital, this study aimed to determine the occurrence of SXT resistance among S. maltophilia isolated from Zagazig University Hospitals, Egypt and to assess the association of sul genes and integron 1 with SXT-resistant isolates.
MATERIAL AND METHODS Study Design and Patient Selection
Across-sectional study was carried out from June 2013 to August 2015 during which samples were collected according to the site of infection from patients admitted to Zagazig University Hospitals. The study was conducted in Medical Microbiology and Immunology Department, Faculty of Medicine, Zagazig University, Egypt. This study was approved by the local institutional review board (Zagazig University IRB). Urine, sputum, endotracheal aspirates (ETA), blood and pus were collected from patients located in different medical wards, surgical wards and ICUs according to the standard microbiological methods. Informed consent was obtained from the patients.
Cultivation and Presumptive Identification of Stenotrophomonas
Isolates Samples were grown on blood and MacConkey agar except urine samples, which were grown on CLED (Oxoid, UK). Blood samples were collected in blood culture bottles containing brain-heart infusion broth and then subcultured onto agar plates (Blood and MacConkey agar). Non-lactose fermenting colonies were identified initially by Gram stain, catalase test, oxidase test, then confirmed to be S. maltophilia by API20NE (Bio-Mérieux, Marcy L'Etoile, France).
Phenotypic Antibiotic Susceptibility Test
The Kirby-Bauer disc diffusion method was employed to determine the antibiotic susceptibility pattern of the isolates using antibiotic discs (Oxoid, UK) on Mueller Hinton agar. All isolates were tested against gentamicin (10µg), amikacin (30µg), levofloxacin (5µg), ciprofloxacin (5µg), imipenem (10µg), trimethoprim/sulphamethoxazole (SXT) (1. 25 
Assessment of SXT Resistance
Genes DNA extraction A single colony was inoculated into Mueller-Hinton broth and incubated for 20 hours at 37C°. After centrifugation at 10000×g for 10 minutes (min), each pellet was washed three times in 750µl TE buffer (10mMTris-HCl, 1mM EDTA, pH 8.0) and then resuspended in 500µl TE buffer. The solution was boiled for 20 min and centrifuged at 10000×g for 10min, and the supernatant was then used as a crude DNA extract in PCR. Extracted DNA was stored at-20°C until further processing.
sul1, sul2 and integron 1 detection Multiplex PCR amplification of sul1, sul2 and integron 1 was conducted as described by Kerrnetal.(13) Amplification of sul1 was performed using the forward primer sul1f (5′-CGG CGT GGG CTA CCT GAA CG-3′) and reverse primer sul1r (5′-GCCGATCGCGTGAAGTTCCG-3′) (433bp).sul2 was identified using the forward primer sul2-F (5′-GCG CTC AAG GCA GAT GGC ATT-3′) and the reverse primer sul2-B (5′-GCG TTT GAT ACC GGC ACC CGT-3′)(293bp). Integron 1 was amplified by using Int-F (5′-GCC ACT GCG CCG TTA CCA CC-3′) and Int-B (5′-GGC CGA GCA GAT CCT GCA CG--3′) (898bp). Additionally, the 16SrRNA gene (auniversal bacterial gene) was amplified in each reaction to serve as an internal positive control using the forward primer 16S-F (5′-GCG GAC GGG TGA GTA ATG T-3′) and reverse primer 16S-B (5′-TCA TCC TCT CAG ACC AGC TA-3′) (200bp). The PCR mixture contained 5µl of template DNA, 5µl of 10×PCR buffer, 10µl of dNTP mix, 4µl of MgCl 2;0 .25µl of AmpliTaq DNA polymerase, 2.5µl of each primer 16S-F, 16S-B (40µM), sul1-F, sul1-B, sul2-F, sul2-B, Int-FandInt-B (2µM) and 5.75µl distilled water. Amplification was carried out by heating for 5 min at 94°C, followed by 30 cycles of 94°C for 15s, 69°C for 30s and 72°C for 60s, followed by one cycle at 72°C for 7 min using Biometra T gradient thermal cycler(Germany).
sul3 detection Different reaction conditions were used to amplify sul3 (14) . PCR was performed using a 25µl reaction of 2µl of boiled lysate, 1×PCR buffer, 3mM MgCl 2,0. 4mM dNTPs, 1.5U of Taq polymerase, 0.4µM sul3F primer (5′-GAG CAA GAT TTT TGG AAT CG-3′) and 0.4µM sul3R primer (5′-CAT CTG CAG CTA ACC TAG GGC TTT GGA-3′) (569bp). Mixtures were centrifuged for 30s at 3000 rpm. Cycling conditions were 98°C for 1min followed by 35 cycles of 98°C for 30s, 51°C for 30s and 72°C for 1min. A final extension was performed at 72°C for 5 min.
Amplicon detection by agarose gel electrophoresis
Ten µl of each amplified DNA & 1500 molecular weight marker (Invitrogen, USA) were separated on 2% agarose gel containing 0.3mg/ml of ethidium bromide. The bands were visualized using UV transilluminator (312nm), photographed & analyzed.
Statistical
analysis Data was analyzed using EPI-INFO 6 for data processing and statistics. Numerical data were expressed as mean and standard deviation. Qualitative data were expressed as frequency and percentage. Chi square test was used to examine the relation between qualitative variables. P value <0.05 was considered significant.
RESULTS
A total of 32 non-duplicate clinical isolates of S.maltophilia were obtained from 300 patients (32/300, 10.6%) admitted to different wards and ICUs at Zagazig University Hospitals, between 2013 and 2015. Isolates were obtained from 18 male (56.25%) and 14 female (43.75%) with a male/female ratio of 1.3:1. The mean age of patients was 64.8±9.65 years (range 48 years to 87 years). The most frequent site of isolation was the respiratory tract (68.7%); including ETA (46.87%) & sputum (21.87%) followed by blood (18.75%), wound (9.4%) then urine (3.12%) (Table1).
The antimicrobial activities of 11 selected antibiotics against 32 S. maltophilia isolates are presented in Table2. All isolates were sensitive to tigecycline and resistant to imipenem. Twelve isolates (37.5%) were resistant to SXT.
The sul genes and integron1 were tested in all the 32 S. maltophilia isolates. All of the 12 SXT-resistant isolates harbored sul1 gene and were positive for integron 1. One isolate among the resistant isolates (1/12) also carried sul2 gene. sul3 gene, on the other hand, had not been detected in any of the resistant isolates. Only 2 of the 20 SXT-susceptible isolates was found to yield positive PCR results for sul1 gene, one of them gave positive result for Integron 1. The association of sul genes and Integron 1 with resistance to SXT had a statistically significant difference (x 2 =23.9, P<0.0001) (Table 3 & Fig.1) . (19) reported that 59% of S. were from respiratory specimen (16.22%), blood (14.87%) and urine Samonis et al. (16) reported that infection associated with S. maltophilia tractinfection (54.4%) followed infections (16.2%), skin and soft (10%) and lastly urinary tract infection
The variation in the percentages may be attributed to the patien studies whether from the intensive or from other hospital wards. Most included in our study were ICU patients, higher occurrence of infections. Overall, results in addition to ours agreed maltophilia may cause many infections, the respiratory tract represents common site affected.
The management of S. maltoph represents a great challenge to problems with in vitro susceptibility (endotracheal swabs and urine with frequencies of respectively. Naeem S. maltophilia isolates followed by wound urine (4.06%). Also, that the main type of maltophilia was respiratory by blood stream soft tissue infections infection (4.4%).
in different studies patients involved in the intensive care units (ICUs)
Most of the patients patients, which led to Overall, the previous agreed that although S.
types of human represents the most maltophilia infections to clinicians due to susceptibility testing, lack of clinical trials to determine optimal therapy, and its intrinsic resistance to a plethora of antimicrobial agents, which severely limits the effectiveness of commonly used empiric antimicrobial therapies (15).
In our study, S. maltophilia isolates were tested against 11 antibiotic to determine their antibiotic sensitivity using the disc diffusion method. The most effective antibiotics in vitro were tigecycline, colistin, levofloxacin, SXT, then ticaricillin-clavulunic and ceftazidime, which showed the highest sensitivity (62.5%) among the β-lactams used in this study. Similar results were obtained by Samonis et al. (16) who reported that colistin and tigecycline could be considered as new therapeutic options against S. maltophilia infections. This is also in line with Zhanel et al. (20) who stated that tigecycline displayed good in vitro activity against MDR isolates of S. maltophilia. Chung et al. (8) reported that tigecycline and levofloxacin have shown good in vitro activity against clinical isolates of S.maltophilia. Other variable findings regarding colistin activity against S. maltophilia isolates were reported (21). This could be explained by differences in the susceptibility testing methods.
Levofloxacin, as one of the new fluoroquinolones, was found to be moderately effective against S. maltophilia, in our study, with 81.25% susceptibility ratio. Similar data from worldwide SENTRY studies has revealed 83.4% sensitivity ratio of S. maltophilia to levofloxacin during the period 2003-2008 (22) which was decreased to 77.3% in2011 (23) . Lower susceptibility rates ranging from 64-69.6% have been reported in Canada (20) , China (24, 25) , and Korea (8). However, it exhibited better potency against S. maltophilia than ceftazidime or ticarcillin-clavulanate in our study, which comes consistent with Chang et al. (3) who reported the same finding. Trimethoprim/sulfamethoxazole has been considered as the mainstay of therapy against S.maltophilia infections. This is primarily based on in vitro susceptibility data rather than clinical studies. However, increasing resistance to trimethoprim/sulfamethoxazole has been reported by several studies and has been mostly related to the horizontal spread of mobile genetic elements carrying resistance genes (16).
In our study, 37.5% of S. maltophilia isolates showed SXT resistance. This comes much higher than a previous Egyptian study done in Mansoura city, which revealed SXT-resistance only in 4.55% of their isolates (26) . This also comes in contrast to Chung et al. (8) who stated that resistance rates vary geographically but are generally lesst han 10%. This difference could be attributed to increased usage of SXT in our local setting. However, high and various rates of resistance to SXT have been reported in patients with cancer, cystic fibrosis and in several countries, including Taiwan, Japan, Korea, Thailand, Spain, Mexico, Saudi Arabia, Turkey, and Canada (16-78.8%) (3). The sul genes and integron 1 were tested in all the 32 S. maltophilia isolates, in our study. All of the 12 SXT-resistant isolates harbored sul1 gene. One isolate among them was additionally positive for sul2 gene. All of the 12SXT-resistant isolates had positive results for integron 1 as well. On the other hand, sul3 gene has not been detected in any of our isolates.
Several investigators have reported that sul1 genes associated with class 1 integrons are the major mechanism of SXT resistance in S. maltophilia. It is worth mentioning that the co-presence of a class 1 integron gene cassette and the sul1 gene in S. maltophilia can further lead to the development of multi-drug resistance and may act as a potential source for the dissemination of resistance. This indeed confirms the importance of strict application of infection control measures in order to decrease the incidence of infections caused by this serious world wide intrinsically drug-resistant pathogen.
Conclusion
In conclusion, this study highlighted the widespread of co-trimoxazole resistance among S. maltophilia isolated from Zagazig University Hospitals, which was much associated with sul1 gene and class 1 integorn. This necessitates continuous surveillance of antimicrobial drug resistance and careful epidemiological monitoring of co-trimoxazole resistance, which has the potential to spread by means of mobile genetic elements. 
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